PlatformQ Health

NeuroSeriesLive

Multiple sclerosis (MS) is a complicated demyelinating disease of the central nervous system, where patients experience a great range of symptoms due to demyelination of nerve fibers. It is characterized by plaques in the brain and spinal fluid. Symptoms that have been observed include numbness, diplopia, cognitive impairment, paralysis, blindness, fatigue, and bladder dystonia. [1]…

Read More >>


PlatformQ Health was proud to present two posters – a traditional poster and an e-poster – at this year’s Annual Meeting of the American Academy of Neurology. Alongside VP of Education Jayne Chaplick, Senior Medical Director Anne Roc attended to present the posters, which focus on insights from previous PQH educational initiatives. While at the meeting,…

Read More >>


PlatformQ Health is pleased to announce our education team will present two poster sessions at the 2018 Annual Meeting of the American Academy of Neurology April 23 and 24 in Los Angeles, California. “We’re proud to be selected to share insights from two of our educational initiatives, one in Multiple Sclerosis (MS) and another in…

Read More >>


March 25 through March 31 marks National Physicians’ Week, a time dedicated to recognizing and thanking doctors for the sacrifices they make to take care of all of us. Doctors work tirelessly to help people when they are most in need, and in spite of the important role they play in our lives, they often…

Read More >>


Pseudobulbaa affect (PBA) typically presents as episodes of uncontrollable laughing or crying that is out of context to the current social situation. The patient’s emotional expression is incongruent to their emotional state. Usually, PBA is seen in the setting of other neurologic diseases such as ALS, Parkinson’s disease, Alzeihmer’s dementia, stroke, progressive MS, brain tumors,…

Read More >>


Alzheimer’s prevalence and impact In the US, Alzheimer’s Disease (AD) is the sixth leading cause of death with greater than 5 million people currently living with the disease. Since the year 2000, deaths from cardiovascular disease have decreased by 14% while there have been an 89% increase in deaths caused by Alzheimer’s. Of people aged over 65…

Read More >>


In this CME offering from NeuroSeriesLive, Dr. Dennis Dlugos takes viewers through the current best practices for pediatric epilepsy. Using two case studies, Dr. Dlugos discusses diagnosis challenges and considerations, goals and concerns of medication treatments, and offers several non-medical treatment options. Dr. Dlugos, Professor of Neurology and Pediatrics at the Perelman School of Medicine…

Read More >>


Migraine headaches are a debilitating collection of neurological symptoms often accompanied by one or more of the following: visual disturbances, nausea, vomiting, dizziness, extreme sensitivity to sound, light, touch, and smell, and tingling or numbness in the extremities or face. A common disorder, about 30 million people in America suffer fro6m this condition to varying…

Read More >>


NeuroSeriesLive and Jefferson Headache Center announce their upcoming event, “Treatment Choices in Acute Migraine Management: Selecting Appropriate Use for Individual Patients.” The interactive online CME session includes Stephen D. Silberstein, MD and Michael J. Marmura, MD from the Center. Dr. Silberstein, the Director of the Jefferson Headache Center, Thomas Jefferson University and his colleague Dr.…

Read More >>



  The 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference, held October 7 through October 10, 2015, in Barcelona, Spain, featured presentations on personalized therapies, updated clinical trials, risk management, and therapeutic strategies for multiple sclerosis treatments. The treatments are likely to be ones doctors will explore for…

Read More >>



  Lennox-Gastaut Syndrome is a form of childhood epilepsy that requires careful diagnosis, treatment and transitional management into adulthood. In “Lennox-Gastaut Syndrome Across the Lifespan: Improving Diagnosis and Management,” a presentation from NeuroSeriesLive, experts Gregory L. Krauss, MD, from Johns Hopkins School of Medicine, and John M. Pellock, MD, at Virginia Commonwealth University discuss the…

Read More >>


By: Rachel Nall, RN, BSN, CCRN Editors Note: This CME session has expired. You can no longer earn CME from this session, however, NeuroSeriesLive.com has many other CME programs, including in Alzheimer’s. To get the latest information, go to NeuroSeriesLive.com After more than three decades of using the same diagnostic criteria for Alzheimer’s disease, recent…

Read More >>


Lennox-Gastaut Virtual CME Symposium Live, Complimentary Online Medical Education Wednesday, November 4, 2015 from 11:00 am – 12:00 noon ET Featured Speakers Gregory L. Krauss, MD Johns Hopkins School of Medicine John M. Lellock, MD Virginia Commonwealth University   Topics include Disease characteristics that may suggest a patient has LGS Differences associated with LGS from…

Read More >>


Our recent event, “New Direction in the Assessment and Management of Patients with Alzheimer’s Disease” was a success with several hundred doctors attending the interactive online broadcast. We compiled a Q&A section of questions from clinicians about the latest treatment and diagnostic options. Dementia Treatment and Diagnostic Options Overall, “eight to 10 million Americans suffer…

Read More >>